Should Shares CRISPR Therapeutics Be a February Pick?
Biotech investors chase game-changing tech, but CRISPR Therapeutics carries real regulatory milestones and execution ...
Compounding is important for investors as it maximizes potential returns over time. Discover its significance in your investment strategy.
27,336 articlesBiotech investors chase game-changing tech, but CRISPR Therapeutics carries real regulatory milestones and execution ...
Caterpillar dominates with record quarterly revenue fueled by data-center power needs, while Deere delivers a solid b...
Rising tensions around the Strait Hormuz critical choke point are sparking volatility in energy markets. Analysts poi...
Desalination facilities in the region are at the center of rising tensions, elevating the mideast’s water supply risk...
A new wave of questions surrounds a16z exec steven sinofsky as reports tie him to Epstein during his Microsoft exit. ...
A rising concentration in a handful of tech names is signaling a wall street flashing warning for many investors. Thi...
A top market strategist calls for exiting the Magnificent 7 amid lofty valuations and fading earnings promises, hinti...
IonQ faces a pivotal year as government and enterprise demand grows for quantum hardware and software. Analysts outli...
AMD delivered a strong Q1 FY2026, prompting a broad uprising in analyst targets. Nine firms boosted price targets as ...
Chevron’s warning on global supply outages could stall U.S. economic momentum, as higher energy costs bite households...
MicroStrategy stock has jumped 43% in the last month as Bitcoin climbs. A new strategy price prediction: mstr model s...
Dow futures slid while oil prices rose as Iran’s stalemate keeps a risk premium in play. Markets brace for inflation ...